ISCHEMIX

Ischemix, Inc., a pharmaceutical company, develops small molecule drugs for the treatment and prevention of ischemia-reperfusion injury. Its product includes CMX-2043, a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule, as well as is used for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention procedures. The company’s drugs also protect against the damaging effects associated with ischemia in brain and other organs. Ischemix, Inc. was formerly known as CereMedix, Inc. and changed its name to Ischemix, Inc. in February 2006. The company was founded in 1999 and is headquartered in Maynard, Massachusetts.

#SimilarOrganizations #People #Website #More

ISCHEMIX

Industry:

Clinical Trials Medical

Founded:

1999-01-01

Address:

Maynard, Massachusetts, United States

Country:

United States

Website Url:

http://www.ischemix.com

Total Employee:

Status:

Active

Contact:

508 839 2999

Total Funding:

6.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apache Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API

Similar Organizations

advanced-cell-diagnostics-logo

Current Employees Featured

not_available_image

Howard Schneider
Howard Schneider Co-founder and Consultant @ Ischemix
Co-founder and Consultant

Founder

not_available_image

Howard Schneider

Official Site Inspections

http://www.ischemix.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K

Host Informations
Whois Informations

Loading ...